Hits, Misses With New Therapies for Neuroendocrine Tumors

(MedPage Today) -- Checkpoint inhibitor flops, CDK4-6 agent moves on, others intrigue

Source: MedPage Today Endocrinology - October 6, 2018 Category: Endocrinology Source Type: news